The Global Fund’s Innovation Coalition: Turning Challenges into Opportunities

Nisa PatelArticle

The Global Fund to Fight AIDS, Tuberculosis and Malaria recently launched the Innovation Coalition, a global, multi-sector partnership platform designed to draw on the innovations, creative energy and solution-oriented approaches of private sector companies, academia and civil society to help solve some of the recurring challenges encountered by Global Fund grant recipients. The Innovation Coalition will identify high-impact opportunities to … Read More

Nisa PatelThe Global Fund’s Innovation Coalition: Turning Challenges into Opportunities

Eli Lilly: Searching for New Tuberculosis Drugs

Nisa PatelArticle

Most TB drugs currently approved for treatment are 50+ years old and are required to be taken over a 6-month period to be effective. Compliance with such a long treatment regimen is a challenge, limiting drugs’ effectiveness and contributing to the rise in MDR-TB. As part of its MDR-TB Partnership, Eli Lilly and Company formed innovative partnerships with the Infectious … Read More

Nisa PatelEli Lilly: Searching for New Tuberculosis Drugs

Meet the PSD: Erika Satterwhite & René Cazetien

Nisa PatelArticle

Erika Satterwhite Manager, Global Policy, Mylan René Cazetien Associate Vice President of Operations, Access to Medicines, Sanofi How did Mylan become involved with the Global Fund? Mylan’s decision to join the PSD Advisory Group is rooted in the company’s desire to provide the often-missing generic manufacturer’s perspective in shaping good public policy around the Global Fund’s efforts to combat HIV/AIDS, TB, … Read More

Nisa PatelMeet the PSD: Erika Satterwhite & René Cazetien

Latest report in RBM’s Progress & Impact Series launches at the United Nations Headquarters in New York

Margaret ArbogastNews

In the margins of the annual High-Level Segment of the United Nations Economic and Social Council (ECOSOC) in New York, RBM gathered health and development leaders from the UN and diplomatic communities to launch the latest report in its Progress & Impact Series to help assess progress towards targets set out in the Global Malaria Action Plan (GMAP) and the … Read More

Margaret ArbogastLatest report in RBM’s Progress & Impact Series launches at the United Nations Headquarters in New York

GBCHealth Honors Laerdal’s Commitment to Maternal and Newborn Health

Nisa PatelNews

25 June 2014 – Laerdal Global Health was today announced as the 2014 winner of the Richard C. Holbrooke Business Leadership Award for Outstanding Contribution to Global Health, GBCHealth’s most prestigious honor. The award recognizes Laerdal Global Health’s exceptional contribution to the health of hundreds of thousands of mothers and babies across the developing world. Eremine Kabanshi, Minister of Community … Read More

Nisa PatelGBCHealth Honors Laerdal’s Commitment to Maternal and Newborn Health

Meet the Private Sector Representatives to the RBM Board

Nisa PatelNews

The PSMC recently elected Private Sector Representatives (PSRs) to the RBM Board for a two-year term beginning May 2014. Hear the new PSRs’ priorities and perspectives on RBM and the global malaria landscape. Jon Pender, Board Member; Vice President, IP & Access, Global Health, GlaxoSmithKline (GSK) Lisa Goldman-Van Nostrand, Board Member; Strategic Advisor, Sumitomo Chemical Nancy Nachbar, Alternate Board Member; … Read More

Nisa PatelMeet the Private Sector Representatives to the RBM Board

The Quest for Greater Effectiveness, Efficiency and Patient Value: Integrating Malaria, Maternal and Child Health Programs.

Nisa PatelNews

by Leith Greenslade Malaria – a child survival success story… The fight against malaria has contributed significantly to the decline in child deaths. The World Malaria Report in 2013 found that between 2000 and 2010 three million fewer children died from malaria.  According to UNICEF, malaria now accounts for just 7 percent of all child deaths – an estimated 460,000 … Read More

Nisa PatelThe Quest for Greater Effectiveness, Efficiency and Patient Value: Integrating Malaria, Maternal and Child Health Programs.

Must Read: Articles from World Malaria Day

Nisa PatelArticle

The global malaria community observed World Malaria Day on April 25th. This year’s theme, “Invest in the Future: Defeat Malaria,” focused attention on the impact of the disease and its implications for the post-2015 development agenda. The world has moved closer to achieving malaria elimination: since 2000, malaria-related deaths have reduced by 42% globally and 49% in Africa, resulting in … Read More

Nisa PatelMust Read: Articles from World Malaria Day

PSC Perspectives: The Burgeoning Problem of Insecticide Resistance

Nisa PatelArticle

By Egon Weinmueller, Head of Business Management Global Public Health, BASF Vector control measures have helped reduce malaria-related sickness and death worldwide.  However, mosquito resistance to insecticides presents a growing challenge. Two thirds of countries with ongoing malaria transmission now report insecticide resistance and without proper intervention[1] the problem could lead to a dramatic and devastating resurgence. Growing metabolic resistance … Read More

Nisa PatelPSC Perspectives: The Burgeoning Problem of Insecticide Resistance

The Global Fund’s New Funding Model and Malaria: Your Questions Answered

Nisa PatelNews

by GBCHealth’s Whitney White, Focal Point for the Private Sector Delegation to the Global Fund Launched in March 2014, the Global Fund’s new approach to grant-making offers recipient countries greater predictability and flexibility. During the 2014-2016 allocation period, the Global Fund will allocate $16.38 billion to the fight against the three diseases (read more about the allocations here.) So, how … Read More

Nisa PatelThe Global Fund’s New Funding Model and Malaria: Your Questions Answered